|
PAN3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63440372347168E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.32689994944724E-09 |
| Normal-vs-Stage2 |
1.52529999741802E-08 |
| Normal-vs-Stage3 |
5.69178038034579E-12 |
| Normal-vs-Stage4 |
9.24859999695826E-08 |
| Stage1-vs-Stage2 |
1.782560E-01 |
| Stage1-vs-Stage3 |
2.845800E-02 |
| Stage1-vs-Stage4 |
1.509440E-01 |
| Stage2-vs-Stage3 |
8.016000E-01 |
| Stage2-vs-Stage4 |
9.407600E-01 |
| Stage3-vs-Stage4 |
8.816800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.33180133587985E-11 |
| Normal-vs-AfricanAmerican |
2.593500E-04 |
| Normal-vs-Asian |
1.22089999998742E-06 |
| Caucasian-vs-AfricanAmerican |
5.230400E-01 |
| Caucasian-vs-Asian |
4.808200E-01 |
| AfricanAmerican-vs-Asian |
9.159800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.36689999985506E-07 |
| Normal-vs-Female |
5.53068701947268E-12 |
| Male-vs-Female |
2.423400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.26039999945615E-08 |
| Normal-vs-Age(41-60Yrs) |
2.38669972674188E-10 |
| Normal-vs-Age(61-80Yrs) |
1.53980050932034E-10 |
| Normal-vs-Age(81-100Yrs) |
1.243320E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.185580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.478400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.699830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.518800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.120400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.418600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.013600E-04 |
| Classical-VS-Follicular |
4.774400E-01 |
| Classical-VS-Other |
7.016600E-01 |
| Classical-VS-Normal |
1.57460000593801E-09 |
| Tall-VS-Follicular |
1.306070E-02 |
| Tall-VS-Other |
1.873180E-01 |
| Tall-VS-Normal |
5.13655784573075E-12 |
| Follicular-VS-Other |
5.907400E-01 |
| Follicular-VS-Normal |
3.49320000037068E-07 |
| Other-VS-Normal |
5.886200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.28193028309443E-12 |
| Normal-vs-N1 |
1.000040E-04 |
| N0-vs-N1 |
2.611600E-01 |
|
|
